Skip to main content Back to Top
Advertisement

8/25/2023

Lisinopril Tablets

Products Affected - Description

    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 90 count, NDC 68180-0514-09 - discontinued
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 5000 count, NDC 68180-0980-30 - discontinued
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 90 count, NDC 68180-0512-09 - discontinued
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 90 count, NDC 68180-0515-09 - discontinued
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 90 count, NDC 68180-0516-09 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 90 count, NDC 68180-0517-09 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 100 count, NDC 68180-0517-01 - discontinued
    • Lisinopril oral tablet, Lupin, 40 mg, bottle, 1000 count, NDC 68180-0517-03 - discontinued
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 90 count, NDC 68180-0513-09 - discontinued

Reason for the Shortage

    • Exelan has lisinopril tablets available for current customers.
    • Lupin has lisinopril tablets available.
    • Major has lisinopril tablets available.
    • Teva has temporarily discontinued lisinopril tablets.

Available Products

    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 45 count, NDC 76282-0419-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 90 count, NDC 76282-0419-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 100 count, NDC 76282-0419-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 76282-0419-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 76282-0417-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 2.5 mg, bottle, 500 count, NDC 76282-0417-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 45 count, NDC 76282-0420-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 90 count, NDC 76282-0420-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 100 count, NDC 76282-0420-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 180 count, NDC 76282-0420-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 76282-0420-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 20 mg, bottle, 5000 count, NDC 76282-0420-50
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 100 count, NDC 76282-0421-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 30 mg, bottle, 500 count, NDC 76282-0421-05
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 45 count, NDC 76282-0422-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 90 count, NDC 76282-0422-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 100 count, NDC 76282-0422-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 180 count, NDC 76282-0422-18
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 40 mg, bottle, 1000 count, NDC 76282-0422-10
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 45 count, NDC 76282-0418-45
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 90 count, NDC 76282-0418-90
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 100 count, NDC 76282-0418-01
    • Lisinopril oral tablet, Exelan Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 76282-0418-10
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 100 count, NDC 68180-0980-01
    • Lisinopril oral tablet, Lupin, 10 mg, bottle, 1000 count, NDC 68180-0980-03
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 100 count, NDC 68180-0512-01
    • Lisinopril oral tablet, Lupin, 2.5 mg, bottle, 500 count, NDC 68180-0512-02
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 100 count, NDC 68180-0981-01
    • Lisinopril oral tablet, Lupin, 20 mg, bottle, 1000 count, NDC 68180-0981-03
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 100 count, NDC 68180-0982-01
    • Lisinopril oral tablet, Lupin, 30 mg, bottle, 500 count, NDC 68180-0982-02
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 100 count, NDC 68180-0513-01
    • Lisinopril oral tablet, Lupin, 5 mg, bottle, 1000 count, NDC 68180-0513-03
    • Lisinopril oral tablet, Major, 10 mg, unit-dose blister pack, 100 count, NDC 00904-6798-61
    • Lisinopril oral tablet, Major, 20 mg, unit-dose blister pack, 100 count, NDC 00904-6799-61
    • Lisinopril oral tablet, Major, 40 mg, unit-dose blister pack, 100 count, NDC 00904-7200-61
    • Lisinopril oral tablet, Major, 5 mg, unit-dose blister pack, 100 count, NDC 00904-6797-61

Updated

Updated August 25, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 30, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT